FDA Inspection
Redox S.r.l.Redox S.r.l. – FDA Inspection, Apr 12, 2019
Record Details
This FDA Inspection record concerns Redox S.r.l., with an inspection on April 12, 2019, issued by the Office of Inspections and Investigations, covering human drugs.
- People
- Amir Alavi (Company Rep)
- Jamie L. Dion (Issuing Officer)
View Company Profile
ID · fd5c2b86-cb6a-4a56-83c1-ec3eb7733344
Inspection Facts
- Inspection number
- 1090329
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Redox S.r.l.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| March 8, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 24, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 20, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 28, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Redox S.r.l.
- FDA Inspection 1269520 - 2023-03-08
- FDA Inspection 1119645 - 2019-05-24
- FDA Inspection 917270 - 2015-02-20
- FDA Inspection 747478 - 2011-09-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.